Early Tocilizumab Dosing is Associated with Improved Survival In Critically Ill Patients Infected With Sars-CoV-2
View ORCID ProfileRussell M. Petrak, View ORCID ProfileNicholas W. Van Hise, View ORCID ProfileNathan C. Skorodin, View ORCID ProfileRobert M. Fliegelman, View ORCID ProfileVishnu Chundi, View ORCID ProfileVishal Didwania, View ORCID ProfileAlice Han, View ORCID ProfileBrian P. Harting, View ORCID ProfileDavid W. Hines
doi: https://doi.org/10.1101/2020.10.27.20211433
Russell M. Petrak
Metro Infectious Disease Consultants: Burr Ridge, Illinois
M.D.Nicholas W. Van Hise
Metro Infectious Disease Consultants: Burr Ridge, Illinois
Pharm.D. BCPSNathan C. Skorodin
Metro Infectious Disease Consultants: Burr Ridge, Illinois
Pharm.D.Robert M. Fliegelman
Metro Infectious Disease Consultants: Burr Ridge, Illinois
D.O.Vishnu Chundi
Metro Infectious Disease Consultants: Burr Ridge, Illinois
M.D.Vishal Didwania
Metro Infectious Disease Consultants: Burr Ridge, Illinois
M.D.Alice Han
Metro Infectious Disease Consultants: Burr Ridge, Illinois
M.D.Brian P. Harting
Metro Infectious Disease Consultants: Burr Ridge, Illinois
M.D.David W. Hines
Metro Infectious Disease Consultants: Burr Ridge, Illinois
M.D.Data Availability
A deidentified dataset and the statistical analysis will be made available to the editor in chief or delegate for a period of 30 days from the time of submission for validation of results.
Posted October 28, 2020.
Early Tocilizumab Dosing is Associated with Improved Survival In Critically Ill Patients Infected With Sars-CoV-2
Russell M. Petrak, Nicholas W. Van Hise, Nathan C. Skorodin, Robert M. Fliegelman, Vishnu Chundi, Vishal Didwania, Alice Han, Brian P. Harting, David W. Hines
medRxiv 2020.10.27.20211433; doi: https://doi.org/10.1101/2020.10.27.20211433
Early Tocilizumab Dosing is Associated with Improved Survival In Critically Ill Patients Infected With Sars-CoV-2
Russell M. Petrak, Nicholas W. Van Hise, Nathan C. Skorodin, Robert M. Fliegelman, Vishnu Chundi, Vishal Didwania, Alice Han, Brian P. Harting, David W. Hines
medRxiv 2020.10.27.20211433; doi: https://doi.org/10.1101/2020.10.27.20211433
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)